Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,699 | Dovepress* | 6,195+ | 1,323 | 7,518 | |
PubMed Central* | 504 | 185 | 689 | ||
Totals | 6,699 | 1,508 | 8,207 | ||
*Since 25 July 2016 |
View citations on PubMed Central and Google Scholar